Science Explorer Back to mapMap
Discussion
Hospital / health system · Louisville · United States

Taustine Eye Center

taustineeyecenter.comROR OpenAlex
Research works
8
▲ 36% vs 2018-21
Citations
315
41.6 per fractional work
Top-10% rate
15.9%
all institutions 10.0%
Open access
24%
world 40%
International
12%
world 18%
Taustine Eye Center

Not ranked overall: Taustine Eye Center is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Taustine Eye Center work in?

In all years, 90% of research at Taustine Eye Center is in Health Sciences, 10% in Life Sciences. Its largest fields are Medicine (89%), Neuroscience (6%), Health Professions (2%). It does 2.1× the world's share of Health Sciences.

Health Sciences: 7 fractional works · 90.5% of its workMedicine: 7 fractional works · 88.5% of its workOphthalmology: 3 fractional works · 34.3% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 18.0% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 16.6% of its workDermatology: 1 fractional works · 9.5% of its workPathology and Forensic Medicine: 0 fractional works · 5.8% of its workEpidemiology: 0 fractional works · 2.5% of its workInfectious Diseases: 0 fractional works · 1.5% of its workHealth Professions: 0 fractional works · 2.0% of its workRadiological and Ultrasound Technology: 0 fractional works · 1.5% of its workPharmacy: 0 fractional works · 0.5% of its workLife Sciences: 1 fractional works · 9.5% of its workNeuroscience: 0 fractional works · 5.7% of its workNeurology: 0 fractional works · 4.1% of its workCognitive Neuroscience: 0 fractional works · 1.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 1.5% of its workCell Biology: 0 fractional works · 1.5% of its workImmunology and Microbiology: 0 fractional works · 1.5% of its workMicrobiology: 0 fractional works · 1.5% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.9% of its workPharmaceutical Science: 0 fractional works · 0.9% of its workALL ITS WORKTaustine EyeCenter8fractional works, all years
Life Sciences10%Health Sciences90%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 6 fields, with their numbers
    1. Medicine788.5%
    2. Health Professions02.0%
    1. Neuroscience05.7%
    2. Biochemistry, Genetics and Molecular Biology01.5%
    3. Immunology and Microbiology01.5%
    4. Pharmacology, Toxicology and Pharmaceutics00.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Taustine Eye Center?

Ranked on the quality score, Ian Benjamin Gaddie lead among researchers whose main affiliation is Taustine Eye Center.

  1. 1 Ian Benjamin Gaddie United States · #1,747,117 worldwide 319 citations · 20 works
All ranked researchers at Taustine Eye Center

What are the most cited papers from Taustine Eye Center?

The most cited paper from Taustine Eye Center is "A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide 11Ms. Clineschmidt, Dr. Adamsons, Dr. Snyder, and Dr. Reines are employees of Merck & Co., Inc., the manufacturer of the dorzolamide-timolol combination. The other authors have no proprietary interest in the dorzolamide-timolol combinati" (Coleen M. Clineschmidt, Robert Williams, Ellen Snyder et al., 1998), with 140 citations. Next come "Ocular Hypotensive Effect of the Rho Kinase Inhibitor AR-12286 in Patients With Glaucoma and Ocular Hypertension" (131) and "Brimonidine and Timolol Fixed-Combination Therapy Versus Monotherapy: A 3-Month Randomized Trial in Patients with Glaucoma or Ocular Hypertension" (80).

Most cited papers
#PaperReleasedCitations
1 A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide 11Ms. Clineschmidt, Dr. Adamsons, Dr. Snyder, and Dr. Reines are employees of Merck & Co., Inc., the manufacturer of the dorzolamide-timolol combination. The other authors have no proprietary interest in the dorzolamide-timolol combinati Coleen M. Clineschmidt, Robert Williams, Ellen Snyder et al. · Ophthalmology Oct 1998 140
2 Ocular Hypotensive Effect of the Rho Kinase Inhibitor AR-12286 in Patients With Glaucoma and Ocular Hypertension Robert D. Williams, Gary D. Novack, Thomas van Haarlem et al. · American Journal of Ophthalmology 29 Jul 2011 131
3 Brimonidine and Timolol Fixed-Combination Therapy Versus Monotherapy: A 3-Month Randomized Trial in Patients with Glaucoma or Ocular Hypertension Earl Randy Craven, Thomas R. Walters, Robert D. Williams et al. · Journal of Ocular Pharmacology and Therapeutics Aug 2005 80
4 Efficacy of bimatoprost in glaucoma and ocular hypertension unresponsive to latanoprost Robert D. Williams · Advances in Therapy Nov 2002 53
5 Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4 Robert D. Williams, JOHN S. COHEN, Ronald L. Gross et al. · British Journal of Ophthalmology 11 Jul 2008 52
All 26 most cited papers, with filters and sorting

Which research topics does Taustine Eye Center publish most on?

By volume in 2022-now: Acne and Rosacea Treatments and Effects, Ocular Surface and Contact Lens, Contact Dermatitis and Allergies and Hidradenitis Suppurativa and Treatments.

Acne and Rosacea Treatme…0Acne and Rosacea Treatments and Effects: 0 fractional worksOcular Surface and Conta…0Ocular Surface and Contact Lens: 0 fractional worksContact Dermatitis and Allergies: 0 fractional worksHidradenitis Suppurativa and Treatments: 0 fractional worksDermatologic Treatments and Research: 0 fractional worksVisual perception and pr…0Visual perception and processing mechanisms: 0 fractional worksDermatology and Skin Diseases: 0 fractional worksHallucinations in medical conditions: 0 fractional worksOphthalmology and Visual…0Ophthalmology and Visual Impairment Studies: 0 fractional works
DermatologyPublic Health, Environmental and Occupational HealthCognitive NeuroscienceEpidemiology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Acne and Rosacea Treatments and Effects Dermatology 0 works
  2. 2 Ocular Surface and Contact Lens Public Health, Environmental and Occupational Health 0 works
  3. 3 Contact Dermatitis and Allergies Dermatology 0 works
  4. 4 Hidradenitis Suppurativa and Treatments Dermatology 0 works
  5. 5 Dermatologic Treatments and Research Dermatology 0 works
  6. 6 Visual perception and processing mechanisms Cognitive Neuroscience 0 works
  7. 7 Dermatology and Skin Diseases Dermatology 0 works
  8. 8 Hallucinations in medical conditions Cognitive Neuroscience 0 works
  9. 9 Ophthalmology and Visual Impairment Studies Epidemiology 0 works
  10. 10 Glaucoma and retinal disorders Ophthalmology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available24.0%not open76.0%

World: 40% of research is openly available.

with international co-authors11.7%domestic only88.3%

World: 18% is written across borders.

How has Taustine Eye Center's research output changed?

Output in 2022-2025 was 36% higher than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Taustine Eye Center as a percentage of every work published that year, 0.000010% in 2024.

still counting0.000025%0.000050%0.000075%Taustine Eye Center0.0000019% in 2025200020102020

Fractional works of Taustine Eye Center over all fractional works that year. How the balance of science has shifted.

Other research institutions in Louisville

All research institutions in Louisville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Taustine Eye Center. Posts are plain text and can be reported.